Commerzbank Aktiengesellschaft FI Boosts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Commerzbank Aktiengesellschaft FI boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 25.5% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,537 shares of the company’s stock after buying an additional 312 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in HCA Healthcare were worth $625,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after buying an additional 60,304 shares during the last quarter. Capital World Investors raised its stake in HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after acquiring an additional 1,019,750 shares during the period. Darsana Capital Partners LP boosted its position in HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares during the period. TD Asset Management Inc lifted its stake in shares of HCA Healthcare by 2.7% during the 2nd quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after buying an additional 19,812 shares in the last quarter. Finally, Epoch Investment Partners Inc. grew its stake in HCA Healthcare by 16.4% in the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after buying an additional 88,948 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,345 shares of company stock worth $5,747,945. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Price Performance

HCA opened at $410.03 on Thursday. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $417.14. The stock’s 50 day simple moving average is $394.72 and its 200 day simple moving average is $352.30. The firm has a market cap of $107.39 billion, a price-to-earnings ratio of 20.44, a PEG ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same quarter last year, the firm earned $4.29 EPS. The company’s revenue was up 10.3% on a year-over-year basis. As a group, analysts predict that HCA Healthcare, Inc. will post 22.51 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. KeyCorp began coverage on HCA Healthcare in a research report on Friday, October 11th. They set an “overweight” rating and a $475.00 price target on the stock. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Morgan Stanley assumed coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price for the company. Finally, StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $367.15.

View Our Latest Stock Report on HCA Healthcare

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.